Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

In vitro and in vivo molecular imaging of estrogen receptor α and β homo- and heterodimerization: exploration of new modes of receptor regulation.

Paulmurugan R, Tamrazi A, Massoud TF, Katzenellenbogen JA, Gambhir SS.

Mol Endocrinol. 2011 Dec;25(12):2029-40. doi: 10.1210/me.2011-1145. Epub 2011 Nov 3.

2.

Autoantibodies to estrogen receptor α interfere with T lymphocyte homeostasis and are associated with disease activity in systemic lupus erythematosus.

Colasanti T, Maselli A, Conti F, Sanchez M, Alessandri C, Barbati C, Vacirca D, Tinari A, Chiarotti F, Giovannetti A, Franconi F, Valesini G, Malorni W, Pierdominici M, Ortona E.

Arthritis Rheum. 2012 Mar;64(3):778-87. doi: 10.1002/art.33400.

3.

Myeloid-specific estrogen receptor alpha deficiency impairs metabolic homeostasis and accelerates atherosclerotic lesion development.

Ribas V, Drew BG, Le JA, Soleymani T, Daraei P, Sitz D, Mohammad L, Henstridge DC, Febbraio MA, Hewitt SC, Korach KS, Bensinger SJ, Hevener AL.

Proc Natl Acad Sci U S A. 2011 Sep 27;108(39):16457-62. doi: 10.1073/pnas.1104533108. Epub 2011 Sep 7. Erratum in: Proc Natl Acad Sci U S A. 2012 Jan 10;109(2):645.

4.

The 2010 Philip S. Portoghese Medicinal Chemistry Lectureship: addressing the "core issue" in the design of estrogen receptor ligands.

Katzenellenbogen JA.

J Med Chem. 2011 Aug 11;54(15):5271-82. doi: 10.1021/jm200801h. Epub 2011 Jul 11. No abstract available.

5.

A role for the MAPK/ERK pathway in oligodendroglial differentiation in vitro: stage specific effects on cell branching.

Younes-Rapozo V, Felgueiras LO, Viana NL, Fierro IM, Barja-Fidalgo C, Manhães AC, Barradas PC.

Int J Dev Neurosci. 2009 Dec;27(8):757-68. doi: 10.1016/j.ijdevneu.2009.08.014. Epub 2009 Sep 1.

PMID:
19729058
6.

Drug and cell type-specific regulation of genes with different classes of estrogen receptor beta-selective agonists.

Paruthiyil S, Cvoro A, Zhao X, Wu Z, Sui Y, Staub RE, Baggett S, Herber CB, Griffin C, Tagliaferri M, Harris HA, Cohen I, Bjeldanes LF, Speed TP, Schaufele F, Leitman DC.

PLoS One. 2009 Jul 17;4(7):e6271. doi: 10.1371/journal.pone.0006271.

7.

Increased exposure to estrogens disturbs maturation, steroidogenesis, and cholesterol homeostasis via estrogen receptor alpha in adult mouse Leydig cells.

Strauss L, Kallio J, Desai N, Pakarinen P, Miettinen T, Gylling H, Albrecht M, Mäkelä S, Mayerhofer A, Poutanen M.

Endocrinology. 2009 Jun;150(6):2865-72. doi: 10.1210/en.2008-1311. Epub 2009 Feb 5.

PMID:
19196801
8.

Intermolecular interactions identify ligand-selective activity of estrogen receptor alpha/beta dimers.

Powell E, Xu W.

Proc Natl Acad Sci U S A. 2008 Dec 2;105(48):19012-7. doi: 10.1073/pnas.0807274105. Epub 2008 Nov 20.

9.
10.

The nuclear receptor superfamily and drug discovery.

Moore JT, Collins JL, Pearce KH.

ChemMedChem. 2006 May;1(5):504-23. Review. No abstract available.

PMID:
16892386
11.

The varied roles of nuclear receptors during vertebrate embryonic development.

Chung AC, Cooney AJ.

Nucl Recept Signal. 2003;1:e007. Epub 2003 Jun 27.

12.

Gender difference in the activity but not expression of estrogen receptors alpha and beta in human lung adenocarcinoma cells.

Dougherty SM, Mazhawidza W, Bohn AR, Robinson KA, Mattingly KA, Blankenship KA, Huff MO, McGregor WG, Klinge CM.

Endocr Relat Cancer. 2006 Mar;13(1):113-34.

13.

Estrogen receptors and human disease.

Deroo BJ, Korach KS.

J Clin Invest. 2006 Mar;116(3):561-70. Review.

14.
15.

Phytoestrogens and antioxidants--bits of experimental evidence.

Mariani SM.

MedGenMed. 2005 Jan 24;7(1):25. No abstract available.

16.

Selective estrogen receptor modulators: discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells.

Frasor J, Stossi F, Danes JM, Komm B, Lyttle CR, Katzenellenbogen BS.

Cancer Res. 2004 Feb 15;64(4):1522-33.

17.

Ciliary neurotrophic factor (CNTF) enhances myelin formation: a novel role for CNTF and CNTF-related molecules.

Stankoff B, Aigrot MS, Noël F, Wattilliaux A, Zalc B, Lubetzki C.

J Neurosci. 2002 Nov 1;22(21):9221-7.

18.
19.

Circumventing tamoxifen resistance in breast cancers using antiestrogens that induce unique conformational changes in the estrogen receptor.

Connor CE, Norris JD, Broadwater G, Willson TM, Gottardis MM, Dewhirst MW, McDonnell DP.

Cancer Res. 2001 Apr 1;61(7):2917-22.

20.

Supplemental Content

Support Center